Fractyl Health, Inc. (GUTS) — Financial statements
Income statement, balance sheet, and cash flow for Fractyl Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00↓100.0% | 0.09↓22.5% | 0.12 | 0.00 | 0.00 | |
| Cost of Revenue | 1↑2158.0% | 0.05↓35.1% | 0.08↓83.0% | 0.45 | 0.00 | |
| Gross Profit | -1↓2725.6% | 0.04↑0.0% | 0.04↑109.5% | -0.45 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 75↑5.8% | 70↑85.3% | 38↑10.7% | 34↑30.0% | 26 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00↓100.0% | 15↑43.2% | 10 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00↑100.0% | -0.45 | 0.00 | |
| SG&A Expenses | 21 | 0.00 | 0.00↓100.0% | 15↑38.9% | 10 | |
| Other Expenses | 0.00↓100.0% | 23↑79.9% | 13 | 0.00 | 0.00 | |
| Operating Expenses | 96↑2.3% | 94↑83.9% | 51↑4.0% | 49↑32.5% | 37 | |
| Total Costs & Expenses | 97↑3.4% | 94↑83.7% | 51↑3.2% | 49↑33.7% | 37 | |
| Operating Results | ||||||
| Operating Income | -97↓3.5% | -94↓84.0% | -51↓2.9% | -49↓33.7% | -37 | |
| Depreciation & Amortization | 1↑66.8% | 0.68↑136.7% | 0.29↓36.7% | 0.45↓33.1% | 0.68 | |
| EBITDA | -96↓3.1% | -93↓83.7% | -51↓3.3% | -49↓35.0% | -36 | |
| EBIT | -97↓3.5% | -94↓84.0% | -51↓2.9% | -49↓33.7% | -37 | |
| Interest & Other Income | ||||||
| Net Interest Income | 2↓62.9% | 4↑229.0% | 1↑58.1% | 0.80↑155.3% | -1 | |
| Interest Income | 2↓62.9% | 4↑229.0% | 1↑58.1% | 0.80 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 1 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | -44↓277.7% | 25↑194.6% | -26↓995.5% | 3↑262.3% | -2 | |
| Income Before Tax | -141↓105.2% | -69↑10.9% | -77↓66.0% | -46↓19.9% | -39 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -141↓105.2% | -69↑10.9% | -77↓66.0% | -46↓19.9% | -39 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -141↓105.2% | -69↑10.9% | -77↓66.0% | -46↓19.9% | -39 | |
| Bottom-Line Net Income | -141↓100.1% | -70↑25.3% | -94↓48.1% | -64↓19.6% | -53 | |
| EPS (Basic) | -1.86↓14.8% | -1.62↑18.2% | -1.98↓47.8% | -1.34↓19.6% | -1.12 | |
| EPS (Diluted) | -1.86↓14.8% | -1.62↑18.2% | -1.98↓47.8% | -1.34↓19.6% | -1.12 | |
| Weighted Average Shares | 76↑74.1% | 44↓8.5% | 48↑0.0% | 48↑0.0% | 48 | |
| Weighted Average Diluted Shares | 76↑74.1% | 44↓8.5% | 48↑0.0% | 48↑0.0% | 48 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.